Epimedin B

CAS No. 110623-73-9

Epimedin B( —— )

Catalog No. M17818 CAS No. 110623-73-9

Epimedin B has potential activity against osteoporosis by stimulating osteoblasts.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 80 In Stock
2MG 34 In Stock
5MG 54 In Stock
10MG 86 In Stock
25MG 140 In Stock
50MG 200 In Stock
100MG 296 In Stock
200MG 436 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Epimedin B
  • Note
    Research use only, not for human use.
  • Brief Description
    Epimedin B has potential activity against osteoporosis by stimulating osteoblasts.
  • Description
    Epimedin B has potential activity against osteoporosis by stimulating osteoblasts.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    110623-73-9
  • Formula Weight
    808.78
  • Molecular Formula
    C38H48O19
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 33.33 mg/mL. 41.21 mM;
  • SMILES
    CC1C(C(C(C(O1)OC2=C(OC3=C(C2=O)C(=CC(=C3CC=C(C)C)OC4C(C(C(C(O4)CO)O)O)O)O)C5=CC=C(C=C5)OC)OC6C(C(C(CO6)O)O)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • A-935142

    A-935142 is a human ether-a-go-go-related gene (hERG, Kv 11.1) channel activator that enhances hERG currents by slowing inactivation, promoting activation, reducing inactivation, and shortening atrial and ventricular repolarization in a complex manner.

  • Anlotinib

    Anlotinib (AL-3818) is a novel multi-target tyrosine kinase that primarily inhibit VEGFR2/3, FGFR1-4, PDGFR α/β, c-Kit, and Ret.

  • AZ5104

    AZ5104, the demethylated metabolite of AZD-9291, is a potent EGFR inhibitor.